Empagliflozin and Liraglutide Differentially Modulate Cardiac Metabolism in Diabetic Cardiomyopathy in Rats

Glucagon-like peptide 1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) are antihyperglycemic agents with cardioprotective properties against diabetic cardiomyopathy (DCM). However, the distinctive mechanisms underlying GLP-1RAs and SGLT2is in DCM are not fully e...

Descripción completa

Detalles Bibliográficos
Autores principales: Trang, Nguyen Ngoc, Chung, Cheng-Chih, Lee, Ting-Wei, Cheng, Wan-Li, Kao, Yu-Hsun, Huang, Shih-Yu, Lee, Ting-I, Chen, Yi-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865477/
https://www.ncbi.nlm.nih.gov/pubmed/33503985
http://dx.doi.org/10.3390/ijms22031177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865477/
https://www.ncbi.nlm.nih.gov/pubmed/33503985
http://dx.doi.org/10.3390/ijms22031177

Ejemplares similares